FORWARD FEATURES CALENDAR

Intelligence

Verdant Leisure buys two premium parks in the North East

Palatine-backed Verdant Leisure has bought two premium leisure parks in County Durham for an undisclosed sum from Park Leisure Holiday Homes. The acquisition of Kingfisher and Heather View holiday parks in the Wear Valley brings the boutique leisure park operator’s portfolio to six sites across southern Scotland and North East

Wynnchurch Capital appoints Caterpillar Mining executive to executive advisory board

Private equity firm Wynnchurch Capital has appointed Chris Curfman to its Executive Advisory Board.  Curfman was most recently President of Caterpillar Global Mining and Senior Vice President of CAT Inc.(NYSE:CAT), the world's leading manufacturer of construction and mining equipment. Curfman's career with Caterpillar Global Mining and CAT Inc. spans over

Pearl Capital Secures USD20m In Funding From Arena Investors

Pearl Capital Business Funding, a provider of direct financing to small and midsize businesses, has closed on a USD20 million financing from Arena Investors, a New York-based global investment firm. "With the support of our outstanding financial partners we can continue to expand our mission of supplying funding to any

IFM Therapeutics raises USD27m Series A financing led by Atlas Venture and Abingworth

Biopharmaceutical company IFM Therapeutics has closed a USD27 million Series A financing led by Atlas Venture and Abingworth, with participation from Novartis.  In conjunction with the funding Jean-François Formela and Vincent Miles, Partners at Atlas and Abingworth respectively, have joined IFM’s CEO, Gary D. Glick, on the board of directors,

BlackFin Capital Partners launches EUR120m Europe focused FinTech venture fund

BlackFin Capital Partners is launching a new venture fund, focusing on FinTech opportunities across Europe. After successfully launching 2 generations of growth-equity financial services funds (Fund I: EUR220 million raised in 2011/Fund II: EUR400 million raised in 2016), BlackFin Capital Partners is leveraging its unique expertise in the venture capital

New chair for Invest Europe

Invest Europe has appointed Dr Gerry Murphy, Senior Managing Director and Chairman of Blackstone Europe, as Chair of the Association. He succeeds Max Römer, Founding Partner of Quadriga Capital.  Murphy has been a senior figure in Blackstone’s team in London since joining the US alternative investments manager in 2008. His

Blackstone makes strategic investment in Marathon Asset Management

Blackstone Strategic Capital Holdings Fund (BSCH), a vehicle managed by Blackstone Alternative Asset Management (BAAM), has acquired a passive, minority interest in Marathon Asset Management.  Based in New York, Marathon is an opportunistic global credit event-driven manager with approximately USD12.75 billion in assets under management. The firm pursues credit through

PwC’s Global 100 Software Leaders driven by three key trends

PwC's new Global 100 Software Leaders ranking illustrates a rapidly shifting landscape and reveals three key trends among companies that are taking advantage of both evolutionary and revolutionary changes in the software industry. Within this shifting environment, the interwoven trends of digital innovation, Industry 4.0 and convergence are driving opportunities

Livingstone secures funding for The Gap Partnership from Pricoa Capital Group

Livingstone’s Business Services and Debt Advisory teams have advised The Gap Partnership Group (TGP) on securing a one-stop funding solution from Pricoa Capital Group. Founded in 1997, TGP is recognised internationally as the leading provider of negotiation behavioural change development programmes and client-specific negotiation consulting services. TGP has a global

IFM Therapeutics raises USD27m Series A Financing led by Atlas Venture and Abingworth

IFM Therapeutics, a biopharmaceutical company developing a portfolio of small molecules targeting the innate immune system, has closed a USD27 million Series A financing led by Atlas Venture and Abingworth, with participation from Novartis.  In conjunction with the funding Jean-François Formela and Vincent Miles, Partners at Atlas and Abingworth respectively,

Events

12 November, 2026 – 5:00 pm

Directory Listings